Switzerland

Switzerland

View Profile →

Singapore-Switzerland Bilateral Trade Analysis 2023

Complete trade statistics: $11.57B total volume •Singapore deficit: $3.67B

SingaporeSwitzerland

$3.95B

Exports (2023)

SwitzerlandSingapore

$7.62B

Imports (2023)

Trade Balance

$3.67B

Deficit for Singapore

Total Trade

$11.57B

Combined Volume

Trade Flow Visualization

Direct trade relationship between Singapore and Switzerland. Green line shows exports from Singapore, red line shows imports.

Detailed Product Trade Analysis

Comprehensive breakdown of trade flows by product category, revealing the specialized nature of the Singapore-Switzerland commercial relationship and competitive positioning in global markets.

SingaporeSwitzerland Exports

$3.95B
2023 Total

Export Market Intelligence

Product Diversity:
Highly Diversified
Market Share:
47.3% top product
1Medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale
$1.87B
47.3% of exports
2Metals: gold, non-monetary, unwrought (but not powder)
$611.70M
15.5% of exports
3Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale
$320.64M
8.1% of exports
4Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale
$300.99M
7.6% of exports
5Jewellery: of precious metal (excluding silver) whether or not plated or clad with precious metal, and parts thereof
$152.73M
3.9% of exports
6Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale
$131.50M
3.3% of exports
7Wrist-watches: (not electrically operated), automatic winding, whether or not incorporating a stop-watch facility, case of precious metal or of metal clad with precious metal
$45.26M
1.1% of exports
8Surveying equipment: theodolites and tacheometers
$41.14M
1.0% of exports
9Wrist-watches: electrically operated, with or without a stop-watch, with case of precious metal or of metal clad with precious metal, with mechanical display only
$24.45M
0.6% of exports
10Wrist-watches: (not electrically operated), (not automatic winding), whether or not incorporating a stop-watch facility, case of precious metal or of metal clad with precious metal
$24.09M
0.6% of exports

🎯 Strategic Export Focus

Singapore's export portfolio to Switzerland demonstrates strong diversification across multiple sectors, with medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale representing a key competitive advantage in this bilateral market.

SwitzerlandSingapore Imports

$7.62B
2023 Total

Import Dependency Profile

Supply Diversity:
Well Diversified
Critical Imports:
18.7% concentration
1Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea and its derivatives, loprazolam, mecloqualone, methaqualone, zipeprol, and salts thereof) n.e.c. in 2933.5
$1.43B
18.7% of imports
2Metals: gold, semi-manufactured
$982.04M
12.9% of imports
3Metals: gold, non-monetary, unwrought (but not powder)
$873.37M
11.5% of imports
4Wrist-watches: (not electrically operated), automatic winding, whether or not incorporating a stop-watch facility, case of precious metal or of metal clad with precious metal
$765.61M
10.1% of imports
5Wrist-watches: whether or not incorporating a stop-watch facility, with automatic winding
$718.10M
9.4% of imports
6Jewellery: of precious metal (excluding silver) whether or not plated or clad with precious metal, and parts thereof
$510.54M
6.7% of imports
7Heterocyclic compounds: n.e.c. in headings no. 2933
$344.45M
4.5% of imports
8Wrist-watches: (not electrically operated), (not automatic winding), whether or not incorporating a stop-watch facility, case of precious metal or of metal clad with precious metal
$188.54M
2.5% of imports
9Medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale
$132.63M
1.7% of imports
10Wrist-watches: electrically operated, with or without a stop-watch, (other than those of heading no. 9101) with mechanical display only
$96.94M
1.3% of imports

📦 Import Strategy Analysis

Singapore's import pattern from Switzerland reveals strategic sourcingin heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea and its derivatives, loprazolam, mecloqualone, methaqualone, zipeprol, and salts thereof) n.e.c. in 2933.5, highlighting complementary economic structures and potential supply chain optimization opportunities.

Competitive Trade Position Analysis

🏆

Market Leadership

Singapore demonstrates competitive strength in exportingmedicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale to Switzerland, leveraging comparative advantages.

Export Leader in 20+ Categories
🔄

Trade Complementarity

The bilateral relationship showsmoderatecomplementarity, with each country specializing in different sectors.

Specialized Exchange
📈

Growth Potential

The $11.57B trade volume indicates substantial economic integration with room for expansion in emerging sectors.

Major Partnership

Executive Summary: Singapore-Switzerland Trade Relationship

Key Trade Highlights 2023

  • Total Trade Volume: $11.57 billionrepresenting a significant bilateral economic relationship
  • Trade Balance: Singapore maintains a deficit of $3.67 billion
  • Export Focus: Singapore's primary exports include medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, metals: gold, non-monetary, unwrought (but not powder), blood, human or animal, antisera, other blood fractions and immunological products: immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale
  • Import Dependencies: Key imports from Switzerland include heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea and its derivatives, loprazolam, mecloqualone, methaqualone, zipeprol, and salts thereof) n.e.c. in 2933.5, metals: gold, semi-manufactured, metals: gold, non-monetary, unwrought (but not powder)

Strategic Trade Indicators

Trade IntensityHigh
Export DiversificationDiversified
Trade Balance HealthImbalanced

📈 Market Position: This bilateral trade relationship represents a significant global trade partnerships, with complementary economic strengths driving sustained commercial exchange.

Historical Trade Analysis & Economic Context

Trade Evolution Timeline

2019-2023: Recent Trends

Current trade volume of $11.57B represents the culmination of evolving bilateral commercial relationships, influenced by global supply chain shifts and changing economic priorities.

2015-2019: Growth Period

Sustained expansion in bilateral trade driven by complementary economic structures, with Singapore leveraging its comparative advantages in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale.

2010-2015: Foundation Building

Establishment of modern trade frameworks and reduction of barriers, facilitating increased commercial exchange and investment flows between the two economies.

Pre-2010: Early Development

Initial stages of bilateral trade relationship development, with focus on traditional export-import patterns and gradual market integration.

Key Economic Drivers

1

Comparative Advantage

Singapore's specialization in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail salecomplements Switzerland's demand patterns, creating natural trade synergies.

2

Supply Chain Integration

Deep integration in global value chains has strengthened bilateral linkages, particularly in heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea and its derivatives, loprazolam, mecloqualone, methaqualone, zipeprol, and salts thereof) n.e.c. in 2933.5.

3

Market Access & Trade Policy

Favorable trade agreements and market access conditions have facilitated the growth of this $11.57B bilateral relationship.

Trade Pattern Insights

Trade ComplementarityAsymmetric
Seasonal VariationsModerate
Product ConcentrationLow
Market DependencyHigh
🔮

Trade Relationship Outlook

The $11.57B bilateral trade volume positions this relationship for continued growth, supported by technological advancement, evolving consumer preferences, and strengthening economic ties. Key opportunities lie in expanding cooperation in emerging sectors while managing potential supply chain vulnerabilities.

Economic Impact & Strategic Outlook

Economic Impact Assessment

💰

Trade Volume Impact

The $11.57 billion bilateral trade volume represents a significant economic factorfor both economies.

Economic Significance: High
🏭

Industrial Integration

Trade flows in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale and heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea and its derivatives, loprazolam, mecloqualone, methaqualone, zipeprol, and salts thereof) n.e.c. in 2933.5 demonstrate deep industrial linkages and supply chain integration.

Supply Chain Integration: Diversified
⚖️

Trade Balance Effects

Singapore's trade deficit of $3.67 billion impacts its overall economic position in this bilateral relationship.

Balance Impact: Import Dependency

Strategic Future Outlook

🚀Growth Opportunities

Emerging Sectors
Technology transfer and innovation cooperation in metals: gold, non-monetary, unwrought (but not powder) present expansion opportunities.
Market Diversification
Beyond current focus on heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea and its derivatives, loprazolam, mecloqualone, methaqualone, zipeprol, and salts thereof) n.e.c. in 2933.5, new product categories offer potential for trade expansion.

⚠️Risk Factors

Supply Chain Vulnerabilities
Moderate concentration in key sectors requires monitoring
Market Competition
Global competition in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale may affect future market positioning.

🎯Strategic Recommendations

  • Strengthen cooperation in high-value sectors beyond current trade patterns
  • Develop alternative supply chains to reduce dependency risks
  • Explore joint ventures in emerging technology sectors
  • Enhance trade facilitation and reduce transaction costs

Market Position & Competitive Summary

The bilateral trade relationship between Singapore and Switzerland represents a total trade volume of $11.57 billion in 2023. This partnership demonstrates an unfavorable trade balance for Singapore, with imports exceeding exportsby $3.67 billion.

Export Strengths

Singapore's exports to Switzerland total $3.95 billion, with competitive advantages in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, representing $1.87B or47.3% of bilateral exports.

Import Dependencies

Imports from Switzerland amount to $7.62 billion, highlighting economic interdependence in heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea and its derivatives, loprazolam, mecloqualone, methaqualone, zipeprol, and salts thereof) n.e.c. in 2933.5, with Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea and its derivatives, loprazolam, mecloqualone, methaqualone, zipeprol, and salts thereof) n.e.c. in 2933.5 comprising18.7% of total imports.

The trade relationship reflects broader economic patterns and comparative advantages. The trade deficit indicates Singapore's strategic sourcing from Switzerland. This partnership is characterized by complementary trade flows, with each country specializing in different product categories based on their respective economic strengths, industrial capabilities, and position in global value chains.

Download Bilateral Trade Data

Access detailed trade data between Singapore and Switzerland in multiple formats.

Data Source: CEPII BACI (Base pour l'Analyse du Commerce International) • Last Updated: January 2025 • Coverage: 1995-2023